Tribridge Partners Financial’s Merck MRK Stock Holding History

Tribridge Partners Financial’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$306K	Hold	2,340	–	–	0.12%	56
2026 Q1	$283K	Buy	+2,340	New	+$270K	0.12%	60

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tribridge Partners Financial's MRK Position: Q2 2026 in Review

Tribridge Partners Financial held its Merck (MRK) position steady in Q2 2026 at 2,340 shares worth $306K. The position accounts for 0.12% of the portfolio, ranked #56.

Tribridge Partners Financial first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Tribridge Partners Financial held 2,340 shares of Merck worth $306K as of Q2 2026.
Tribridge Partners Financial left its Merck share count unchanged in Q2 2026.
Merck made up 0.12% of Tribridge Partners Financial's portfolio in Q2 2026, its #56 holding.
Tribridge Partners Financial first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tribridge Partners Financial's 13F filing for Q2 2026, filed 4 Aug 2026.